4//SEC Filing
BIOCRYST PHARMACEUTICALS INC 4
Accession 0001127602-12-010719
$BCRXCIK 0000882796operating
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 12:21 PM ET
Size
4.6 KB
Accession
0001127602-12-010719
Insider Transaction Report
Form 4
SANDERS CHARLES A
Director
Transactions
- Purchase
Common Stock
2012-03-13$5.21/sh+2,000$10,430→ 7,000 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.24. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882796
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 12:21 PM ET
- Size
- 4.6 KB